Orthofix director granted 20,721 deferred units

Orthofix Medical Inc. director Michael Finegan reported receiving an award of 20,721 deferred stock units of common stock.

Rhea-AI Filing Summary

Orthofix Medical Inc. director Michael Finegan reported receiving an award of 20,721 deferred stock units of common stock. These units vest in full on the first anniversary of the grant date, contingent on his continued service. Each deferred stock unit represents the right to receive one Orthofix common share, which will be delivered within 45 days after his service with the company ends. Following this award and previously reported positions, Finegan now holds a total of 81,617 Orthofix shares and deferred stock units, including 55,805 earlier deferred units and 3,505 shares acquired under Orthofix's Stock Purchase Plan.

Insider Trade Summary

Grant/Award: 20,721 shares

Grant/Award 1 txn

Insider Finegan Michael

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	20,721	$0.00	$0.00

Holdings After Transaction: Common Stock — 81,617 shares (Direct)

Footnotes (2)

1. F1. Represents an award of deferred stock units that vest in full on the first anniversary of the grant date, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer.
2. F2. Includes 55,805 previously reported deferred stock units and an aggregate of 3,505 shares acquired under Orthofix's Stock Purchase Plan ("Orthofix's SPP") on 10/31/2025 and 4/30/2026. Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5), and share acquisitions under the plan are exempt from Section 16(b).

Key Figures

Deferred stock units granted: 20,721 units Total holdings after transaction: 81,617 shares/units Previously reported deferred units: 55,805 units +4 more

7 metrics

Deferred stock units granted 20,721 units Award to director Michael Finegan on grant date

Total holdings after transaction 81,617 shares/units Common stock and deferred stock units following award

Previously reported deferred units 55,805 units Deferred stock units held before new grant

Shares from Stock Purchase Plan 3,505 shares Acquired under Orthofix’s SPP on 10/31/2025 and 4/30/2026

Grant price per unit $0.00 Compensation-related award, not open-market purchase

Vesting schedule 1-year cliff vesting Units vest in full on first anniversary of grant

Settlement timing Within 45 days Conversion into common stock after termination of service

Key Terms

deferred stock units, Orthofix's Stock Purchase Plan, Rule 16b-3(b)(5), Section 16(b), +1 more

5 terms

deferred stock units financial

"Represents an award of deferred stock units that vest in full on the first anniversary of the grant date"

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

Orthofix's Stock Purchase Plan financial

"Includes 55,805 previously reported deferred stock units and an aggregate of 3,505 shares acquired under Orthofix's Stock Purchase Plan"

Rule 16b-3(b)(5) regulatory

"Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5)"

Section 16(b) regulatory

"share acquisitions under the plan are exempt from Section 16(b)"

A federal rule that requires company insiders—like officers, directors and large shareholders—to return any profits made from buying and selling the company’s stock within a six-month window. It matters to investors because it discourages short-term trades that could exploit non-public information and helps protect outside shareholders by creating a simple, enforceable way to recover unfair gains, much like a rule stopping someone from flipping a limited-edition item for quick profit after getting early access.

contingent right financial

"Each deferred stock unit represents a contingent right to receive one share of common stock"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Orthofix (OFIX) director Michael Finegan report in this Form 4?

Michael Finegan reported receiving 20,721 deferred stock units of Orthofix common stock. These were granted at no cost as a compensation award, increasing his total reported holdings to 81,617 shares and units, including earlier deferred units and shares from the company’s stock purchase plan.

How do Michael Finegan’s new Orthofix (OFIX) deferred stock units vest?

The 20,721 deferred stock units vest in full on the first anniversary of the grant date. Vesting is conditioned on Finegan’s continued service with Orthofix through that date, aligning his compensation with ongoing board service over the coming year.

When will Michael Finegan receive Orthofix (OFIX) shares from these deferred stock units?

Each vested deferred stock unit will convert into one Orthofix common share within 45 days after Finegan’s termination of service. This means settlement is deferred until he leaves the company, spreading the delivery of shares into the future rather than immediately.

What are Michael Finegan’s total reported Orthofix (OFIX) holdings after this transaction?

After the award, Finegan’s total reported position is 81,617 Orthofix shares and deferred stock units. This includes the new 20,721-unit grant, 55,805 previously reported deferred stock units, and 3,505 shares acquired under Orthofix’s Stock Purchase Plan on two prior dates.

What is Orthofix’s Stock Purchase Plan mentioned in Michael Finegan’s Form 4?

Orthofix’s Stock Purchase Plan is described as a “Stock Purchase Plan” under Rule 16b-3(b)(5). The Form 4 notes that 3,505 shares were acquired under this plan and that acquisitions through it are exempt from Section 16(b) short-swing profit rules for insider transactions.

Was Michael Finegan’s Orthofix (OFIX) award an open-market stock purchase?

No, the Form 4 characterizes the transaction as a grant or award acquisition coded “A,” with a zero per-share price. This indicates compensation-related deferred stock units rather than an open-market stock purchase executed at a market price.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/12/2026 - 06:28 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Finegan Michael

(Last) (First) (Middle)

3451 PLANO PARKWAY

(Street)

LEWISVILLE TEXAS 75056

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Orthofix Medical Inc. [ OFIX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/10/2026		A		20,721(1)	A	$0	81,617(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of deferred stock units that vest in full on the first anniversary of the grant date, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer.

2. Includes 55,805 previously reported deferred stock units and an aggregate of 3,505 shares acquired under Orthofix's Stock Purchase Plan ("Orthofix's SPP") on 10/31/2025 and 4/30/2026. Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5), and share acquisitions under the plan are exempt from Section 16(b).

	/s/ J. Andres Cedron, attorney-in-fact	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)